ISSN 1662-4009 (online)

ESPE Yearbook of Paediatric Endocrinology (2022) 19 13.8 | DOI: 10.1530/ey.19.13.8

ESPEYB19 13. Global Health for the Paediatric Endocrinologist Diabetes (6 abstracts)

13.8. Improving access to diabetes care for children: an evaluation of the changing diabetes in children project in Kenya and Bangladesh

Palmer T , Jennings HM , Shannon G , Salustri F , Grewal G , Chelagat W , Sarker M , Pelletier N , Haghparast-Bidgoli H & Skordis J


Institute for Global Health, University College, London, London, UK; Department of Health Sciences, University of York, York, UK; Global Health Disrupted, Nairobi, Kenya; Diabetic Association of Bangladesh, Dhaka, Bangladesh


t.palmer@ucl.ac.uk Pediatr Diabetes 2022; 23:19–32. doi: 10.1111/pedi.13277

Brief Summary: The Changing Diabetes in Children (CDiC) program successfully established a stable supply of free insulin in implementing facilities for children living in Kenya and Bangladesh. However, the program also has limitations, including concerns over its sustainability.

The greatest benefit of the implementation of the “Changing Diabetes in Children“ (CDiC) program in Kenya and Bangladesh has been the provision of a stable supply of free insulin for children (although the type of insulin was most commonly human premixed insulin (Mixtard®) which is now rarely used in high-income countries and is not recommended by ISPAD in youth with type 1 diabetes). Other supplies (such as syringes, lancets, glucose strips and glucometers) and education are also offered by CDiC. However, the provision of diabetes care includes many aspects that go well beyond the provision of insulin: dedicated facilities and accessibility to the clinics, staff training and appropriate capacity, education material for patients, availability of supplies and cost of laboratory investigations, to name a few.

The most important message of this article relates to future sustainability of diabetes care in these countries and how the health authorities in Bangladesh and Kenya are planning to progressively decrease their dependence to CDiC. Clearly, the price of insulin, which remains extremely high (see comment on WHO prequalification in paper 13.1 of this chapter) is a major issue. The authors highlight the role that the government is expected to play: care of young adults once they graduate from the program, increased resource allocation to the growing issue of diabetes, better infrastructure, to name a few.